Science Explorer Back to mapMap
Discussion
Company · Versailles · France

Viotech Communications (France)

Research works
45
▲ 64% vs 2018-21
Citations
2k
45.1 per fractional work
Top-10% rate
2.5%
all institutions 10.0%
Open access
27%
world 40%
International
28%
world 18%

Not ranked overall: Viotech Communications (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Viotech Communications (France) work in?

In all years, 52% of research at Viotech Communications (France) is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (16%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 23 fractional works · 52.1% of its workMedicine: 23 fractional works · 52.1% of its workRadiology, Nuclear Medicine and Imaging: 7 fractional works · 14.8% of its workOncology: 3 fractional works · 7.8% of its workImmunology and Allergy: 2 fractional works · 3.8% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 3.5% of its workHematology: 1 fractional works · 2.4% of its workPhysiology: 1 fractional works · 2.4% of its workReproductive Medicine: 1 fractional works · 2.2% of its workEpidemiology: 1 fractional works · 2.1% of its workPathology and Forensic Medicine: 1 fractional works · 1.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.6% of its workSurgery: 1 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.5% of its workDermatology: 1 fractional works · 1.3% of its workInfectious Diseases: 1 fractional works · 1.3% of its workHepatology: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.7% of its workEmergency Medicine: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workTransplantation: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.2% of its workLife Sciences: 16 fractional works · 34.9% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 16.3% of its workMolecular Biology: 5 fractional works · 11.8% of its workGenetics: 1 fractional works · 2.8% of its workBiotechnology: 1 fractional works · 1.2% of its workEndocrinology: 0 fractional works · 0.2% of its workCell Biology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 7 fractional works · 15.7% of its workImmunology: 6 fractional works · 13.1% of its workVirology: 1 fractional works · 2.2% of its workParasitology: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 2.4% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.2% of its workBehavioral Neuroscience: 0 fractional works · 0.7% of its workDevelopmental Neuroscience: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workFood Science: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workPhysical Sciences: 5 fractional works · 10.2% of its workComputer Science: 2 fractional works · 4.7% of its workComputer Networks and Communications: 1 fractional works · 2.2% of its workComputer Vision and Pattern Recognition: 1 fractional works · 1.5% of its workSignal Processing: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 3.1% of its workElectrical and Electronic Engineering: 1 fractional works · 2.0% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workMedia Technology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workEnvironmental Science: 1 fractional works · 1.4% of its workEcology: 1 fractional works · 1.4% of its workChemistry: 0 fractional works · 0.5% of its workSpectroscopy: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 2.8% of its workSocial Sciences: 1 fractional works · 1.2% of its workSociology and Political Science: 1 fractional works · 1.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 0.4% of its workSocial Psychology: 0 fractional works · 0.4% of its workALL ITS WORKViotechCommunications…45fractional works, all years
Life Sciences35%Physical Sciences10%Health Sciences52%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine2352.1%
    1. Biochemistry, Genetics and Molecular Biology716.3%
    2. Immunology and Microbiology715.7%
    3. Neuroscience12.4%
    4. Agricultural and Biological Sciences00.4%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Computer Science24.7%
    2. Engineering13.1%
    3. Environmental Science11.4%
    4. Chemistry00.5%
    5. Physics and Astronomy00.2%
    6. Earth and Planetary Sciences00.2%
    1. Social Sciences11.2%
    2. Economics, Econometrics and Finance01.1%
    3. Psychology00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.56× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 6.60× its world share, 0 worksImmunology and Micro…Earth and Planetary Sciences: 1.51× its world share, 0 worksEarth and Planetary …Engineering: 0.90× its world share, 0 worksEngineeringEnvironmental Science: 0.48× its world share, 0 worksEnvironmental SciencePhysics and Astronomy: 1.52× its world share, 0 worksPhysics and AstronomyMedicine: 3.58× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.6×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology6.60×0 works
  2. Medicine3.58×2 works
  3. Physics and Astronomy1.52×0 works
  4. Earth and Planetary Sciences1.51×0 works
  5. Engineering0.90×0 works
  6. Biochemistry, Genetics and Molecular Biology0.56×0 works
  7. Environmental Science0.48×0 works

Who are the top researchers at Viotech Communications (France)?

Ranked on the quality score, J M Le Doussal and A. Morel lead among researchers whose main affiliation is Viotech Communications (France).

  1. 1 J M Le Doussal France · #2,045,092 worldwide 719 citations · 20 works
  2. 2 A. Morel France · #2,206,465 worldwide 826 citations · 23 works
All ranked researchers at Viotech Communications (France)

What are the most cited papers from Viotech Communications (France)?

The most cited paper from Viotech Communications (France) is "Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon" (Marina Cella, David Jarrossay, Fabio Facchetti et al., 1999), with 1,739 citations. Next come "Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials" (469) and "Tetramer-based quantification of cytomegalovirus (CMV)–specific CD8+ T lymphocytes in T-cell–depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection" (280).

Most cited papers
#PaperReleasedCitations
1 Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon Marina Cella, David Jarrossay, Fabio Facchetti et al. · Nature Medicine Aug 1999 1,739
2 Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials Birgit Sawitzki et al. · The Lancet Open access May 2020 469
3 Tetramer-based quantification of cytomegalovirus (CMV)–specific CD8+ T lymphocytes in T-cell–depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection Jan Willem Gratama, Joost W. J. van Esser, C. B. H. W. Lamers et al. · Blood Open access Sep 2001 280
4 A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues J. M. Wang, S. Kumar, David Alexander Pye et al. · International Journal of Cancer 28 May 1993 185
5 Immunoanalysis of histamine through a novel chemical derivatization A. Morel, Michel A. DELAAGE · Journal of Allergy and Clinical Immunology Oct 1988 184
All 61 most cited papers, with filters and sorting

Which keywords describe research at Viotech Communications (France)?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Antibody Engineering, Fc Receptors, Cancer, Immune Response and Inflammation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Monoclonal Antibodies5▲ 77×3 topics
  2. Therapeutic Antibodies5▲ 85×2 topics
  3. Glycosylation4▲ 45×3 topics
  4. Inflammation4▲ 4.2×13 topics
  5. Antibody Engineering4▲ 95×1 topic
  6. Fc Receptors4▲ 95×1 topic
  7. Cancer4▲ 6.3×7 topics
  8. Epidemiology3▲ 1.88×14 topics
  9. Immune Response3▲ 12×5 topics
  10. Autoimmunity3▲ 31×4 topics
  11. Cancer Immunotherapy2▲ 40×2 topics
  12. Immunotherapy2▲ 7.3×5 topics
  13. PET Imaging2▲ 19×3 topics
  14. Tumor Microenvironment2▲ 11×2 topics
  15. Foxp32▲ 49×1 topic
  16. IL-62▲ 108×1 topic
  17. STAT32▲ 108×1 topic
  18. TGF-ß2▲ 21×1 topic
  19. Targeted Therapy2▲ 17×2 topics
  20. Antigen Presentation2▲ 32×1 topic
  21. Dendritic Cells2▲ 28×1 topic
  22. Drug Discovery2▲ 8.4×2 topics
  23. Immunity2▲ 10×3 topics
  24. Lymphoma1▲ 20×3 topics
  25. NK Cell Recognition1▲ 32×1 topic
  26. Natural Killer Cells1▲ 32×1 topic
  27. Radioimmunotherapy1▲ 80×1 topic
  28. Radiopharmaceuticals1▲ 80×1 topic
  29. Tumor Regression1▲ 35×2 topics
  30. Antiretroviral Therapy1▲ 12×4 topics
  31. Crystal Structure1▲ 11×2 topics
  32. Neuroendocrine Control1▲ 41×2 topics
  33. Vaccine1▲ 6.5×3 topics
  34. Asthma1▲ 19×2 topics
  35. HIV1▲ 20×2 topics
  36. AIDS1▲ 43×1 topic
  37. Antibodies1▲ 25×1 topic
  38. CAR T Cells1▲ 53×1 topic
  39. Chimeric Antigen Receptor1▲ 53×1 topic
  40. PET/CT1▲ 29×1 topic

Which research topics does Viotech Communications (France) publish most on?

By volume in 2022-now: Medical Imaging Techniques and Applications, Hepatitis C virus research, Medical Imaging and Pathology Studies and Advanced Biosensing Techniques and Applications.

  1. 1 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Hepatitis C virus research Hepatology 0 works
  3. 3 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 0 works
  4. 4 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  5. 5 Photonic and Optical Devices Electrical and Electronic Engineering 0 works
  6. 6 Semiconductor Lasers and Optical Devices Electrical and Electronic Engineering 0 works
  7. 7 Advancements in PLL and VCO Technologies Electrical and Electronic Engineering 0 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 0 works
  9. 9 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  10. 10 Hepatitis B Virus Studies Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.0%not open73.0%

World: 40% of research is openly available.

with international co-authors27.6%domestic only72.4%

World: 18% is written across borders.

How has Viotech Communications (France)'s research output changed?

Output in 2022-2025 was 64% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Viotech Communications (France) as a percentage of every work published that year, 0.000037% in 2024.

still counting0.00020%0.00040%0.00060%Viotech Communications (France)0.0000053% in 20251990200020102020

Fractional works of Viotech Communications (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Versailles

All research institutions in Versailles

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Viotech Communications (France). Posts are plain text and can be reported.